The authors had previously demonstrated a role of TRIB3 in promoting STAT3 phosphorylation/activation in NSCLC (98), with targeted therapeutic degradation of TRIB3 promoting STAT1 protein stability and resultant Cxcl10 transcription (71). The gene discussed is TRIB3; the disease is non-small cell lung carcinoma.